Approaches to the early treatment of invasive fungal infection

Area of Science:

• Mycology
• Infectious Diseases
• Hematology

Background:

• Invasive fungal infections (IFIs) cause significant mortality in immunocompromised patients, particularly those with hematologic malignancies and hematopoietic cell transplant recipients.
• Delays in appropriate antifungal therapy contribute to high mortality rates from IFIs.
• Predictive tests for preemptive antifungal therapy are lacking, necessitating alternative strategies.

Purpose of the Study:

• To present an approach for managing invasive candidiasis and invasive mold infections.
• To emphasize the importance of early empiric antifungal therapy in improving survival rates.

Main Methods:

• Initiating therapy at the first signs and symptoms of disease.
• Selecting appropriate antifungal agents based on local fungal epidemiology.
• Considering the patient's recent antifungal agent exposure.
• Utilizing immediately available diagnostic tests.

Main Results:

• Early empiric therapy is the current best approach to improve survival in IFIs.
• Tailoring therapy based on specific patient and local factors is key.

Conclusions:

• Prompt initiation of empiric antifungal therapy is essential for high-risk patients.
• A strategic approach considering epidemiology, patient history, and diagnostics improves outcomes for invasive fungal infections.